SAB Biotherapeutics SABS
NASDAQ SABS
$2.98 -0.08 (-2.61%)
At close: Oct 2, 2026 · 4:00 PM EDT

SAB Biotherapeutics (SABS) Change in Acquisitions & Divestments (2021)

Updated

SAB Biotherapeutics (SABS) posted Change in Acquisitions & Divestments of $116.15 million for Q1 2021.

Analysis

SAB Biotherapeutics (SABS) Change in Acquisitions & Divestments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 SAB Biotherapeutics 248.81 Mn 248.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 116.15 Mn
API Access

SAB Biotherapeutics Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=SABS&period=max&api_key=YOUR_API_KEY